General remarks
All reactions were carried out with commercial available reagents. Analytical thin layer chromatography (TLC) was performed using Merck 60 F254 precoated silica gel plates with UV 254 indicator. Toluene, THF, EtOAc and CH2Cl2 was purchased as analytical pure. CH2Cl2 was dried with NaH under distilled condition. THF and Toluene was dried and distilled from sodium benzophenone. Melting points (m.p.) were measured on electrothermal digital melting point apparatus from Beijing Fukai Instruments Co.Ltd. 1 H NMR spectra were recorded on Bruker AMX 300 or 600 MHz with CDCl3 or CD3OD as sovent. Chemical shifts were reported in ppm from SiMe4 (δ 0.0) and the signal of CDCl3 (δ7.26 singlet) and CD3OD (δ3.31 singlet). 13 C NMR spectra were recorded with CDCl3 and CD3OD as sovent. Chemical shifts were reported in ppm from SiMe4 (δ 0.0) and the signal of CDCl3 (δ77.0 triplet) and CD3OD (δ49.0 singlet).
Enantiomeric excesses (ee) were determined by high performance liquid chromatogr aphy (HPLC) using corresponding commercial chiral column at 30 ˚C with Hatachidetector 254 or 210 nm.
Optical rotations were reported as follows: [α] 20 D (c g/100 mL, in solvent). 13 C NMR spectra were collected on commercial instruments (100 or 150 MHz) with complete proton decoupling. Chemical shifts are reported in ppm from the tetramethylsilane with the solvent resonance as internal standard (CDCl3, δ = 77.0, t). High resolution mass spectrometry (HRMS) was measured on a commercial apparatus (ESI Source micrOTOF).
The racemic products used to determine the e.e. values were obtained by using 1,1,3,3-tetramethylguanidine (TMG) as catalyst.
Typical preparation of glycine imine schiff base
Scheme S1. The synthesis of glycine imine schiff base General Procedure for the Preparation of the glycine esters adlmines 4 according to previously report [1] . To a solution of the corresponding amino acid ester chlorhydrate (30mmol, 1 equiv ) in CH2Cl2 (45 mL) were added MgSO4 and NEt3 (33 mmol, 1.1 equiv). The resulting mixture was stirred at the room temperature for 30 min. Then the aldehyde (30 mmol, 1 equiv) was added, and the resulting mixture was stirred for 16 h. Then the obtained sulution was filtered out and the organic layer washed with water, dried, and evaporated. The imines showed satisfactory NMR spectra. (Some of 4 were purified by base flash column chromatography).
(E)-ethyl 2-((2-hydroxybenzylidene)amino)acetate(4a)
According to the above procedure, afford 4a, light yellow oil；90% yield； 1 2. The preparation of sulfonyl imine [2] TiCl4 (1.1 mL, 10 mmol, 0.5 quvic) in dry CH2Cl2 (10 mL) was added dropwise to a stirred, Scheme S2. The synthesis of sulfonyl imines 5a-5c.
The method for preparation of 5d-5j can be found in previously report [3] .
Scheme S3. The synthesis of sulfonyl imine 5d-5i 
The preparation of chiral guanidine
General procedure: The method for preparation of 6a-6h following the above procedure can be found in previously report [4] . Scheme S4. The synthesis route of guanidine catalyst (6a-6h)
The preparation of (4R,5R)-4,5-diphenylimidazolidin-2-imine 6i according to previously literature [5] .
Scheme S5. The synthesis route of chiral guanidine 6i (1R,2R)-1,2-diphenylethane-1,2-diamine (1 g, 4.7 mmol) was dissolved in MeCN (5 mL).
The obtained solution was cooled to 0 °C, and a 1 M solution of cyanogen bromide in MeCN (4.7 mL, 4.7 mmol) was added dropwise via syringe. The mixture was equiped a reflux condenser and heated at reflux for 48 h. The solution was concentrated and purified by column chromatography to afford white foam. The guanidinium salt was basified by dissolving in CH2Cl2 and adding oil-free NaH. The suspension was shaken for thirty seconds, filtered through Celite, and concentrated to provide the guanidine 6i as a white powder in 51% yield. 1 The preparation of 1,3-bis((S)-1-phenylethyl)imidazolidin-2-imine 6j an be found in previously report [5] .
Scheme S6. The synthesis route of chiral guanidine 6j [5] .
The method for preparation of 6j-a can be found in previously literature [6] . 6j was Prepared as described for 6i. 1 H NMR (600 MHz, CDCl3) δ 7.45 -7.30 (m, 8H), 7.26 (t, J = 6.9 Hz, 3H), 5.15 (s, 2H),
The preparation of N-((4R,5R)-1,3-dimethyl-4,5-diphenylimidazolidin-2-ylidene)-1-pheny lmethanamine 6k [1] .
Scheme S7. The synthesis route of chiral guanidine 6k.
The method for preparation of 6k-c can be found in previously report [7] .
A solution of 6k-c (3.0 g, 11.3 mmol) and oxalyl chloride (1.6 g, 12.4 mmol) in anhydrous toluene (100 ml) was refluxed for 12.5 h. After cooling, the precipitate was filtered, repeatedly washed with anhydrous toluene, and dried under reduced pressure to give 6k-d as colorless solid.
The crude solid was used for next step without further purification.
To a solution of a benzylamine (0.33 g, 3.1 mmol) and Et3N (0.66 mg, 6.5 mmol) in CH2Cl2 (30 ml) was added dropwise a solution of 6k-d (1 g) in CH2Cl2 (15 ml) at rt. The mixture was stirred at RT for 1 hour and poured into dil. HCl, and extracted with dichloromethane. The organic solution was evaporated to dryness. The residue was dissolved in water and washed with toluene.
The aqueous solution was made alkaline with dil. aq. NaOH and extracted with CH2Cl2. The obtained organic solution was dried and evaporated to yield pure guanidines 6k as white solid. The preparation of chiral di-guanidine catalyst 6l was found in previously literature [8] .
Scheme S8. The synthesis route of chiral guanidine 6l
Product 6l was obtained following the literature procedure, matching the previously published characterization data. The ee and dr value was determined by HPLC analysis using a Chiralpak AD-H (Hexane/i-PrOH = 90/10, flow rate 1.0 mL/min, λ = 254 nm), tR (major diastereomer,) = 61.5min The ee and dr value was determined by HPLC analysis using a Chiralpak AD-H (Hexane/i-PrOH = 90/10, flow rate 1.0 mL/min, λ = 254 nm), tR (major diastereomer,) = 42.9min
The Typical Mannich-type reaction

Generality explorations of the Mannich-type reaction (E)-ethyl 2-((3,5-di-tert-butyl-2-hydroxybenzylidene)amino)-3-(quinoline-8-sulfonamido)-3-(p-tolyl)propanoate
(major enantiomer); 11.5min (minor enantiomer). Scheme S10. Determination of absolute configuration According to the above procedure, afford 7p, light yellow oil；80% yield；Saturated HCl solution of AcOMe (6 ml) was added slowly to a stirred solution of 7p (1 g, 1.5 mmol) in CH2Cl2 (10 ml) at 0oC. The solution was stirred for 2h at 0°C and warmed to room temperature and was stirred for another 5 h. After that, the obtained solution was dried and evaporated to afford crude product 8a as yellow solid. Crude solid 8a (0.40 g) , benzophenone imine and 10 ml CH2Cl2, were stirred at room temperature for 20 h with the exclusion of moisture (CaCl2 tube). The reaction mixture was filtered to remove NH4Cl and evaporated. The residue was purified by flash chromatography on silica gel to afford 9a (140 mg, 42% yield in two steps) as white solid, matching the previously published characterization data [9] . The ee and dr value was determined by HPLC analysis using a Chiralpak AD-H (Hexane/i-PrOH = 90/10, flow rate 1.0 mL/min, λ = 254 nm), tR (major diastereomer,) = 33.8min
ESI-HRMS: calcd for C36H43N3O5SH + ([M+H
(major enantiomer); 37.0 min (minor enantiomer). major diastereomer (ee = 29)/ minor diastereomer (ee = 42) = 1.7:1, Minutes   16  18  20  22  24  26  28  30  32  34  36  38  40  42  44  46  48 Major diastereomer (ee = 26) / minor diastereomer (ee = 43) = 1.1:1. Therefore, the ee of major diastereomer is in accord with 9a. Then, according to the literature of Shin-ichi Fukuzawa and co-workers [9] , compared (2S,3S)-methyl 2-((diphenylmethylene)amino)-3-(4-methylphenylsulfonamido)-3-phenylpropanoate with other isomer, the absolute configuration of this mainly Mannich product is (2S,3S) . 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190 
